PDD 00031705

Discontinued Product

7009 has been discontinued.

View all Poly(ADP-ribose) Glycohydrolase products.
说明: Negative control for PDD 00017238 (Cat. No. 7007)
化学名: 1-[(2,4-Dimethyl-5-thiazolyl)methyl]-2,3-dihydro-N-methyl-N-(1-methylcyclopropyl)-2-oxo-3-(1,2,4-thiadiazol-5-yl)-1H-benzimidazole-5-sulfonamide
纯度: ≥98% (HPLC)
说明书
引用文献 (1)
评论
文献 (1)

生物活性 for PDD 00031705

PDD 00031705 is a negative control for PDD 00017238 (Cat. No. 7007).

技术数据 for PDD 00031705

分子量 490.62
公式 C20H22N6O3S3
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 2032096-45-8
PubChem ID 123131658
InChI Key KWGUETFSHQZXMA-UHFFFAOYSA-N
Smiles CN(S(=O)(C1=CC=C2N(C(N(C2=C1)C3=NC=NS3)=O)CC4=C(N=C(S4)C)C)=O)C5(CC5)C

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for PDD 00031705

参考文献是支持产品生物活性的出版物。

James et al (2016) First-in-class chemical probes against poly(ADP-ribose) glycohydrolase (PARG) inhibit DNA repair with differential pharmacology to Olaparib. ACS Chem.Biol. 11 3179 PMID: 27689388

按产品操作查看相关产品

查看全部 Poly(ADP-ribose) Glycohydrolase Controls

关键词: PDD 00031705, PDD 00031705 supplier, PDD00031705, poly, ADP, ribose, glycohydrolase, PARG, inhibitors, negative, controls, Poly(ADP)-ribose, Glycohydrolase, 7009, Tocris Bioscience

1 篇 PDD 00031705 的引用文献

引用文献是使用了 Tocris 产品的出版物。 PDD 00031705 的部分引用包括:

Craig A et al (2018) Hypoxia induces pulmonary fibroblast proliferation through NFAT signaling. Sci Rep 8 2709 PMID: 29426911


PDD 00031705 的评论

目前没有该产品的评论。 Be the first to review PDD 00031705 and earn rewards!

Have you used PDD 00031705?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.